Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype

Shahmanesh, M., Jaleel, H., DeSilva, Y., Ross, J., Caslake, M. and Cramb, R. (2001) Protease inhibitor related type III hyperlipoproteinaemia is common and not associated with apolipoprotein-E E2/E2 phenotype. Sexually Transmitted Infections, 77, pp. 283-286.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Caslake, Professor Muriel
Authors: Shahmanesh, M., Jaleel, H., DeSilva, Y., Ross, J., Caslake, M., and Cramb, R.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Medical Veterinary and Life Sciences
Journal Name:Sexually Transmitted Infections

University Staff: Request a correction | Enlighten Editors: Update this record